|
Status |
Public on Aug 06, 2013 |
Title |
Minimal Change Disease, H1-Glom-MCD3 |
Sample type |
RNA |
|
|
Source name |
Kidney Biopsy from Human Minimal Change Disease
|
Organism |
Homo sapiens |
Characteristics |
tissue: Glomeruli from kidney biopsy disease status: Minimal Change Disease
|
Treatment protocol |
None
|
Growth protocol |
None
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated using RNeasy kit (Qiagen) following manufacturer's protocol.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from total RNA (Expression Analysis Technical Manual, Affymetrix).
|
|
|
Hybridization protocol |
Standard Affymetrix protocol.
|
Scan protocol |
GeneChip arrays were scanned by GeneChip Scanner 3000 7G according to the Affymetrix Expression Analysis Technical Manual.
|
Description |
Gene Expression data from the glomeruli of human Minimal Change Disease kidney
|
Data processing |
The data were analyzed using GenePattern pipeline: RMA method and Human Entrez Gene custom CDF annotation version 10 was used for the normalization. Each of the hybridization was normalized separately and the VALUE column contains the batch-corrected data using Combat.
|
|
|
Submission date |
May 22, 2013 |
Last update date |
Aug 07, 2013 |
Contact name |
Viji Nair |
E-mail(s) |
[email protected]
|
Organization name |
University of Michigan
|
Street address |
1152 West Medical Centre Dr.
|
City |
Ann Arbor |
ZIP/Postal code |
48331 |
Country |
USA |
|
|
Platform ID |
GPL14663 |
Series (2) |
GSE47183 |
In silico nano-dissection: defining cell type specificity at transcriptional level in human disease (glomeruli) |
GSE47185 |
In silico nano-dissection: defining cell type specificity at transcriptional level in human disease |
|